Recent Updates
Recently added Catalysts
TECH

Bio-Techne Announces Appointment Of Julie L. Bushman To Its Board Of Directors Bio-Techne Corporation (NASDAQ:TECH) today announced the appointment of Julie L. Bushman to serve as an independent director on the company's board...

Key Takeaway: MINNEAPOLIS , Aug. 3, 2020 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH ) today announced the appointment of Julie L. Bushman to serve as an independent director on the company's board of directors, effective as of July 31, 2020 . Following the appointment, the board of B

Full Press Release Details

MINNEAPOLIS , Aug. 3, 2020 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH ) today announced the appointment of Julie L. Bushman to serve as an independent director on the company's board of directors, effective as of July 31, 2020 . Following the appointment, the board of Bio-Techne will be comprised of ten directors, nine of whom are independent.
Bushman, 59, is the former Executive Vice President of International Operations for 3M . She previously served in various executive positions at 3M , including as Senior Vice President of Business Transformation and Information Technology; Executive Vice President of Safety, Security and Protection Services; Executive Vice President of Safety and Graphics; Division Vice President of the Occupational Health and Environmental Safety Division; and Chief Information Officer. Bushman joined 3M in 1983.
Bushman currently serves as a director of Adient plc, an automotive seating company and Phillips 66, an energy manufacturing and logistics company, and the Regions Hospital Foundation. She previously served as a director of Johnson Controls from 2012 through 2016.
"We are pleased to welcome Julie to our board," said Bob Baumgartner , Chair of the Board of Bio-Techne. "She brings tremendous global experience from managing 3M's international operations, as well as other global business roles while at 3M . She also has extensive digital, software and CIO experience, which will bring important expertise as Bio-Techne continues to expand globally and integrate systems to increase operational efficiencies."
About Bio-Techne Corporation (NASDAQ: TECH )
Contact: David Clair , Senior Director, Investor Relations & Corporate Development [email protected] 612-656-4416
SOURCE Bio-Techne Corporation

Related Links

21 %

Last updated: Aug 3, 2020